967. Inhibition of host neuraminidase increases susceptibility to invasive pulmonary aspergillosis
Session: Oral Abstract Session: Fungal Infections
Friday, October 5, 2018: 10:30 AM
Room: W 2002
Background: Influenza-associated aspergillosis (IAA) is an emerging fungal infection with high mortality and morbidity and the pathogenesis of this disease is not well understood. Interestingly, the number of IAA case reports has increased since the widespread use of neuraminidase-inhibitors, such as oseltamivir in 2009. We set out to determine whether oseltamivir could contribute to the pathogenesis of IAA by modulating host responses.

Methods: First, peripheral blood mononuclear cells (PBMCs) and neutrophils from healthy donors were stimulated with neuraminidase (NA)-treated A. fumigatus or were pre-exposed to NA prior to stimulation with Aspergillus conidia. In addition, PBMCs and neutrophils were pre-treated with oseltamivir carboxylate prior to stimulation. Cytokines were measured from supernatants after 24 hours of incubation at 37˚C. C57BL/6 and BALB/c mice were treated with oseltamivir prior to intranasal challenge with A. fumigatus. Immunosuppression was induced by corticosteroid or cyclophosphamide.

Results: We demonstrate that Aspergillus treated with NA induced an enhanced immune response. Moreover PBMCs and neutrophils treated with NA produced increased cytokine responses. Blocking NA in vitro with oseltamivir reduced Aspergillus-induced cytokine responses. Next we investigated the effects of blocking neuraminidase activity with oseltamivir in vivo. Immunocompetent mice and mice treated with corticosteroids showed increased mortality, lung fungal burden, and decreased cytokine production when treated with oseltamivir. These effects were not observed in cyclophosphamide-treated mice, suggesting that the effects of NA activity in anti-Aspergillus host defense acts mainly via myeloid cells.

Conclusion: Our results provide evidence that host neuraminidase activity is important for protective anti-Aspergillus immune responses. Treatment with oseltamivir, thus blocking host NA activity, in a setting of corticosteroid use might therefore increase susceptibility to Aspergillus infection. These results warrant further study on the role of neuraminidase and the effects of oseltamivir on susceptibility to invasive pulmonary aspergillosis during active influenza infection.

Frank Van De Veerdonk Jr., MD, PhD1, Intan Dewi, MD2, Christina Cunha, PhD3, Lore vanderBeeke, MD4, Martin Jaeger, PhD2, Mark Gresnigt, PhD2, Agustin Resendiz, PhD5, Katrien Lagrou, PhD6, Greetje Van De Velde, PhD7, Joost Wauters, MD7 and Agostinho Carvalho, PhD3, (1)Radboud University, Nijmegen, Netherlands, (2)Radboudumc, Nijmegen, Netherlands, (3)Braga University, Braga, Portugal, (4)University of Leuven, Leuven, Belgium, (5)UZ Leuven, Leuven, Netherlands, (6)National Reference Centre for Invasive Streptococcus Pneumoniae, University Hospitals Leuven - KU Leuven, Leuven, Belgium, (7)UZ Leuven, Leuven, Belgium

Disclosures:

F. Van De Veerdonk Jr., None

I. Dewi, None

C. Cunha, None

L. vanderBeeke, None

M. Jaeger, None

M. Gresnigt, None

A. Resendiz, None

K. Lagrou, None

G. Van De Velde, None

J. Wauters, None

A. Carvalho, None

See more of: Fungal Infections
See more of: Oral Abstract Session
Previous Abstract | Next Abstract >>

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.